Bromoacetylalprenololmenthane
Names | |
---|---|
IUPAC name 2-bromo-N-[2-[4-[[2-hydroxy-3-(2-prop-2-enylphenoxy)propyl]amino]-4-methylcyclohexyl]propan-2-yl]acetamide | |
Identifiers | |
CAS Number |
|
3D model (JSmol) |
|
Abbreviations | BAAM, BrAAM |
ChEMBL |
|
ChemSpider |
|
MeSH | Bromoacetylalprenololmenthane |
PubChem CID |
|
CompTox Dashboard (EPA) |
|
InChI
| |
| |
Properties | |
Chemical formula | C24H37BrN2O3 |
Molar mass | 481.475 g·mol−1 |
log P | 4.14 |
Acidity (pKa) | 13.844 |
Basicity (pKb) | 0.153 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). N verify (what is YN ?) Infobox references |
Chemical compound
Bromoacetylalprenololmenthane (BAAM or BrAAM) is a β adrenergic receptor agonist.[1]
References
- ^ Rainer-Joachim; Matthys Staehelin (20 April 1987). "Bromoacetylalprenololmenthane binding to β-receptors modulates the rate of hormone-induced internalization but not desensitization in S49 cells". FEBS Letters. 214 (2): 323–326. doi:10.1016/0014-5793(87)80079-0. PMID 3032686.
- v
- t
- e
Adrenergic receptor modulators
- See also: Receptor/signaling modulators
- Dopaminergics
- Serotonergics
- Monoamine reuptake inhibitors
- Monoamine releasing agents
- Monoamine metabolism modulators
- Monoamine neurotoxins
This drug article relating to the cardiovascular system is a stub. You can help Wikipedia by expanding it. |
- v
- t
- e